Healthcare | April 07, 2026
World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
Zydus has developed an innovative formulation of Semaglutide Injection in a prefilled cartridge administered using a reusable patient-friendly pen device
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
At the center of the announcement are two late-breaking studies that could reshape treatment approaches for patients with high cholesterol and a complex form of heart failure
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
Subscribe To Our Newsletter & Stay Updated
